Sign in

CIK 0000072444 · Accelerated filer<br>Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
591212264
Phone
(650) 550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
  1. UPLOAD Other SEC-generated Letter
  2. DEFA14A Proxy Proxy Materials
  3. DEFA14A Proxy Proxy Materials
  4. UPLOAD Other SEC-generated Letter
  5. DFAN14A Other Proxy Soliciting Materials
  6. DEFC14A Other DEFC14A
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 8-K Event Material agreement
  10. DEFM14A Deal DEFM14A
  11. DEFA14A Proxy Proxy Materials
  12. SC TO-I/A Deal Tender Offer Statement by Issuer
  13. SC 13D/A Stake Beneficial Ownership Report
  14. SC TO-I/A Deal Tender Offer Statement by Issuer
  15. SC 13D/A Stake Beneficial Ownership Report
  16. PRRN14A Other PRRN14A
  17. 8-K Event Other events
  18. DEFA14A Proxy Proxy Materials
  19. SC TO-I/A Deal Tender Offer Statement by Issuer
  20. UPLOAD Other SEC-generated Letter

Page 47 of 89 · 1,773 filings